NAM
CRL icon

Nissay Asset Management’s Charles River Laboratories CRL Stock Holding History

Nissay Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,217
Closed -$1.16M – 734
2024
Q4 		$1.16M Buy
6,217
+58
+0.9% +$11.2K 0.01% 625
2024
Q3 		$1.21M Buy
6,159
+190
+3% +$39.5K 0.01% 625
2024
Q2 		$1.23M Buy
5,969
+128
+2% +$29K 0.01% 599
2024
Q1 		$1.58M Buy
5,841
+92
+2% +$22K 0.01% 561
2023
Q4 		$1.36M Buy
5,749
+223
+4% +$43.9K 0.01% 564
2023
Q3 		$1.08M Buy
5,526
+186
+3% +$38.2K 0.01% 593
2023
Q2 		$1.12M Sell
5,340
-36
-0.7% -$7.16K 0.01% 585
2023
Q1 		$1.08M Sell
5,376
-181
-3% -$41K 0.01% 583
2022
Q4 		$1.21M Sell
5,557
-111
-2% -$24.2K 0.01% 553
2022
Q3 		$1.11M Buy
5,668
+239
+4% +$51.6K 0.01% 561
2022
Q2 		$1.16M Sell
5,429
-168
-3% -$41.1K 0.01% 553
2022
Q1 		$1.59M Buy
5,597
+136
+2% +$41.9K 0.01% 522
2021
Q4 		$2.06M Buy
5,461
+107
+2% +$41.6K 0.02% 469
2021
Q3 		$2.21M Buy
5,354
+188
+4% +$78.1K 0.02% 433
2021
Q2 		$1.91M Buy
+5,166
New +$1.73M 0.02% 458

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Nissay Asset Management's CRL Position: Q1 2025 in Review

Nissay Asset Management sold out of Charles River Laboratories (CRL) in Q1 2025, closing a stake of 6,217 shares — an estimated $1.16M sold.

Nissay Asset Management first reported a position in CRL in Q2 2021 and held it in 15 quarters. The position peaked at $2.21M in Q3 2021. 561 funds tracked by Wall St. Rank hold CRL as of Q1 2025.

  • Nissay Asset Management reported no remaining Charles River Laboratories position as of Q1 2025 after selling out during the quarter.
  • Nissay Asset Management sold 6,217 Charles River Laboratories shares in Q1 2025, an estimated $1.16M.
  • Nissay Asset Management first reported a position in Charles River Laboratories in Q2 2021 and held it in 15 quarters.
  • Nissay Asset Management's Charles River Laboratories position peaked at $2.21M in Q3 2021.
  • 561 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2025.

Based on Nissay Asset Management's 13F filing for Q1 2025, filed 15 May 2025.